233 results on '"Banerjee, Arinjay"'
Search Results
2. Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
3. Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada
4. The translational potential of studying bat immunity
5. ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
6. Genomic and transcriptomic characterization of delta SARS-CoV-2 infection in free-ranging white-tailed deer (Odocoileus virginianus)
7. Evolutionary trajectory of SARS-CoV-2 and emerging variants
8. Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
9. Urban Bats, Public Health, and Human-Wildlife Conflict
10. Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors
11. Molecular, ecological, and behavioral drivers of the bat-virus relationship
12. Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways
13. Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters
14. Clash of the titans: interferons and SARS-CoV-2
15. Correction for Rasmussen et al., “Virology—the path forward”
16. SARS-CoV-2 3CLpro Main Protease Drives Cytoskeletal Reorganization and Tunnelling Nanotube Formation for Stealth Intercellular Infection
17. Probe design for simultaneous, targeted capture of diverse metagenomic targets
18. Molecular Determinants of SARS-CoV-2 Variants
19. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
20. Urban Bats, Public Health, and Human-Wildlife Conflict
21. Unraveling the Zoonotic Origin and Transmission of SARS-CoV-2
22. SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.
23. Bat Influenza Viruses: Making a Double Agent of MHC Class II
24. Positive Selection of a Serine Residue in Bat IRF3 Confers Enhanced Antiviral Protection
25. Virology—the path forward
26. Efficacy of a stable multivalent broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
27. Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2
28. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2
29. Tools to study pathogen-host interactions in bats
30. Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus
31. Comparative study of innate immune gene landscape in bat cells
32. Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus
33. Generation and Characterization of Eptesicus fuscus (Big brown bat) kidney cell lines immortalized using the Myotis polyomavirus large T-antigen
34. Coupling field and laboratory studies of immunity and infection in zoonotic hosts
35. Reference-quality bat genomes illuminate adaptations to viral tolerance and disease resistance
36. Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals
37. Versatile use of bat ACE2 for cellular entry by MERS-CoV-like viruses
38. Developing the Tools to Manage Complex Crises : Training Students in Interdisciplinarity
39. Strengthening a One Health approach to emerging zoonoses
40. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
41. Laying the foundation for single-cell studies in bats
42. Controlling Nipah virus encephalitis in Bangladesh: Policy options
43. The novel 2019 coronavirus (nCoV) infection in humans: A Systematic Review Protocol
44. Human coronaviruses disassemble processing bodies
45. Probe design for simultaneous, targeted capture of diverse metagenomic targets
46. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
47. BCG vaccination provides protection against IAV but not SARS-CoV-2
48. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
49. Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation
50. The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.